Main Session
Sep
29
SS 31 - Mechanisms of Resistance and Normal Tissue Toxicity
261 - Clinical and Genomic Landscape of Recurrence After Concurrent Chemoradiotherapy and Adjuvant Immunotherapy in Unresectable NSCLC
Presenter(s)
Kolade Olabode, MD, MPH - Moffitt Cancer Center, Tampa, FL